DTIL

Precision BioSciences

This company develops in vivo gene editing therapies for patients with genetic and infectious diseases using its proprietary ARCUS genome editing platform.

Beam Therapeutics

The company develops precision genetic medicines using base editing technology to treat patients with serious genetic diseases such as sickle cell disease.

LogicBio

This company develops gene editing and delivery platforms to provide one-time treatments for patients with serious, early-onset rare genetic diseases.

ARTV

This clinical-stage biotechnology company develops natural killer cell therapies for patients with autoimmune diseases and cancers.

Stylus Medicine

This biotechnology company develops in vivo genetic medicines using engineered recombinases and lipid nanoparticles for patients with cancer, autoimmune and genetic diseases.

Dyne

This company develops therapeutics for patients with genetically driven neuromuscular diseases.

EDITAS Medicine

The company develops CRISPR-based genome editing medicines to treat patients with serious genetic diseases, including blood disorders and inherited eye conditions.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.